A critical reevaluation of the "therapeutic range" of aminoglycosides.
about
Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy"Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens.Prevention of adverse events in hospitalized patients using an antimicrobial review program.Minimisation of aminoglycoside toxicity in patients with cystic fibrosisAntibacterial action of extracts of Clinopodium vulgare L. curative plant.Aminoglycoside dosing in diabetes.A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit.Pharmacological issues in the treatment of tuberculosis.Ototoxicity induced by gentamicin and furosemide.A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infantsExtended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: Systematic Review.Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study.Therapeutic drug monitoring in pediatrics: a need for improvement.Aminoglycoside dosing considerations in intensive care unit patients.Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.Single or multiple daily doses of aminoglycosides: a meta-analysis.Tobramycin population pharmacokinetics in neonates.Pharmacological risk factors for amphotericin B nephrotoxicity in children.Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material.High-dose gentamicin in newborn infants: is it safe?Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.An evaluation of serum gentamicin concentrations and bacterial susceptibility to gentamicin in equine practice.
P2860
Q28379292-B225B2A9-7F3C-47B2-874D-7FFC32B656AEQ33236907-DC13AAF6-77D1-4287-9256-421BC3903ECEQ33772759-AE98AFA2-6CCC-4BBE-9EC9-82FC421820ADQ33775991-66ACB861-3C32-404E-BAFA-9E51654FB627Q33854594-27715C6E-0603-4D43-8A37-18085CA9149EQ33940442-8889ACC1-BD09-4B0A-BA84-9E0C668B3CB6Q34146978-884C9EDD-F60B-46BE-8527-0CB292E1212AQ34497277-48413E81-4E89-4535-A0DE-959CD1714899Q34521641-317CD47C-EAAC-4CA5-A1B2-40852992C581Q35279846-52227CC5-6D69-43AA-961B-F5028F688FD3Q35745888-A64875BD-551E-40DC-B466-1AEC8E8C41CCQ38285837-32E48DA9-0B57-4B83-9FCE-F9A02B09262CQ38596654-901E11A8-0CF9-4794-A04D-4A313D068E1DQ39616905-536425FC-8E23-4595-86F5-F4C8C873071CQ39779327-467AE22F-2D7B-489E-96F4-D7F61F89B183Q39941380-4E9BC26F-53CC-4100-A1C6-2A8E671A639EQ40666608-5162E184-7CDB-4BC1-8D88-437F01B16302Q40794034-53FFB189-8773-46A2-A15D-E01BD8CF2E3AQ41055433-363B3C20-AE34-4302-9295-B5006B02CB33Q41966523-3159202B-B32F-4631-958A-E7FD72E9D7ECQ42145555-99FFDAE8-F83A-4BEE-A068-1C406B9F2892Q42666715-F2B66FFB-9FC1-4F58-87AA-EC44BFB728A1Q43599634-A0EA7F9A-3476-469F-852D-2490FDA74D98Q43678070-4864B0F6-3EBA-41E9-921B-F463B0EDD661Q43716998-D7704943-6BFB-4C7E-91CB-435EE41DEABDQ44905354-1B4A9F2A-0B56-4FA0-AD60-70356E742E42Q45070708-85CA0F5B-B802-45D1-A07D-2C795381D7F4Q50356292-934B91C0-5382-4D77-AC8C-8FD71B9F2CD0Q52300060-ED00AE56-3191-420C-8779-6F8E18A125DAQ54249096-FB1518B6-38C6-4264-8252-D4E7869C385A
P2860
A critical reevaluation of the "therapeutic range" of aminoglycosides.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@ast
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@en
type
label
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@ast
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@en
prefLabel
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@ast
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@en
P356
P1476
A critical reevaluation of the "therapeutic range" of aminoglycosides.
@en
P2093
Jewesson PJ
McCormack JP
P304
P356
10.1093/CLINIDS/14.1.320
P407
P577
1992-01-01T00:00:00Z